
Vitamin B6 (pyridoxine)
The inactive supplemental form of vitamin B6 that the liver converts to the active coenzyme PLP. Cheapest, most widely tested form — used in every major clinical guideline (ACOG NVP, Wyatt PMS). Strong evidence for correcting deficiency and as first-line therapy for pregnancy nausea. The unique caveat: chronic high doses cause sensory neuropathy, and EFSA (2023) now caps the safe daily limit at 12 mg.
Quick decision guide
May help most
Pregnant women with morning sickness (10–25 mg, 3–4×/day per ACOG), people on B6-depleting drugs (isoniazid, cycloserine), and correcting documented B6 deficiency.
Common dosing range
1.3–2.0 mg/day RDA from diet; 10–100 mg/day for clinical indications (PMS, NVP, deficiency).
When to expect effects
Days to weeks for NVP; weeks for PMS; weeks for biomarker correction in deficiency.
Watch out for
Don't take >100 mg/day long-term without a clinician — sensory neuropathy is dose-dependent. EFSA now uses a 12 mg/day ceiling.
Evidence snapshot
What is it
Pyridoxine is the most common supplement form of vitamin B6, used to support amino acid metabolism, red blood cell formation, and neurotransmitter synthesis. The body converts it to the active coenzyme pyridoxal 5-phosphate.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Correcting B6 deficiency Strong Evidence | Normalizes plasma PLP within 2–6 weeks at 10–50 mg/day | Adults with CKD, IBD, alcohol use disorder, post-bariatric surgery, or on isoniazid / cycloserine / hydralazine / penicillamine | Weeks for biomarker correction |
Nausea and vomiting of pregnancy (NVP) Good Evidence | Significant reduction in nausea score; combination with doxylamine ~70% reduction vs placebo | Pregnant women with mild-to-moderate morning sickness | Days to 1–2 weeks |
Lowering homocysteine Good Evidence | Reliable homocysteine reduction in combination with folate + B12; HOPE-2 showed ~25% stroke reduction; most other large CV trials negative | People with documented hyperhomocysteinemia or homocystinuria | Weeks for biomarker; years for any hard endpoint |
Premenstrual syndrome (PMS) Limited Evidence | OR 2.32 for overall symptom improvement (Wyatt 1999); modest effect sizes in newer single trials | Women with PMS featuring mood symptoms (irritability, low mood, anxiety) | 1–3 menstrual cycles |
Correcting B6 deficiency
- Effect
- Normalizes plasma PLP within 2–6 weeks at 10–50 mg/day
- Best fit
- Adults with CKD, IBD, alcohol use disorder, post-bariatric surgery, or on isoniazid / cycloserine / hydralazine / penicillamine
- Time
- Weeks for biomarker correction
Nausea and vomiting of pregnancy (NVP)
- Effect
- Significant reduction in nausea score; combination with doxylamine ~70% reduction vs placebo
- Best fit
- Pregnant women with mild-to-moderate morning sickness
- Time
- Days to 1–2 weeks
Lowering homocysteine
- Effect
- Reliable homocysteine reduction in combination with folate + B12; HOPE-2 showed ~25% stroke reduction; most other large CV trials negative
- Best fit
- People with documented hyperhomocysteinemia or homocystinuria
- Time
- Weeks for biomarker; years for any hard endpoint
Premenstrual syndrome (PMS)
- Effect
- OR 2.32 for overall symptom improvement (Wyatt 1999); modest effect sizes in newer single trials
- Best fit
- Women with PMS featuring mood symptoms (irritability, low mood, anxiety)
- Time
- 1–3 menstrual cycles
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Correcting B6 deficiency
Corrects deficiencyPyridoxine reliably raises plasma PLP and corrects clinical deficiency. RDA: 1.3 mg/day for adults 19–50; 1.7 mg/day (men 51+), 1.5 mg/day (women 51+). People at elevated deficiency risk include chronic kidney disease, IBD, alcohol use disorder, and patients on B6-antagonist drugs (isoniazid, cycloserine, hydralazine, penicillamine). Standard correction doses of 10–50 mg/day restore plasma PLP within weeks. Pyridoxine HCl is the form used in every clinical guideline.
Bottom line: Pyridoxine HCl at 10–50 mg/day is the standard, well-evidenced form for deficiency correction.
Nausea and vomiting of pregnancy (NVP)
Supplement benefitACOG Practice Bulletin 189 (2018) names pyridoxine 10–25 mg orally 3–4×/day as first-line pharmacotherapy for NVP, alone or combined with doxylamine 12.5 mg (the Diclegis/Diclectin combination). Multiple RCTs show statistically significant reductions in nausea severity; the doxylamine combination shows ~70% reduction in nausea/vomiting versus placebo. Safety data covering hundreds of thousands of pregnancies shows no increase in birth defect risk. The Matthews 2015 Cochrane review found monotherapy evidence less consistent than combination therapy, but ACOG still endorses pyridoxine alone as a safe first step.
Bottom line: First-line, ACOG-recommended. Try pyridoxine alone first; add doxylamine if needed.
Lowering homocysteine
Biomarker supportPyridoxine is a cofactor for cystathionine beta-synthase, the enzyme that disposes of homocysteine. B6 + folate + B12 combinations reliably lower plasma homocysteine. The HOPE-2 trial showed a 25% stroke-risk reduction with this triple combination. However, despite reliable biomarker lowering, most large CV outcome trials (VISP, NORVIT, WAFACS) have failed to show clinically meaningful reductions in heart attacks or all-cause mortality.
Bottom line: Useful for proven hyperhomocysteinemia. Don't take it as general heart-attack prevention.
Evidence is mixed
Reliable biomarker lowering does not translate into reliable cardiovascular event reduction in most large RCTs.
Premenstrual syndrome (PMS)
Supplement benefitThe Wyatt 1999 BMJ systematic review pooled 9 RCTs (940 women) and found pyridoxine up to 100 mg/day produced an overall symptom-improvement OR of 2.32 (95% CI 1.95–2.54) and a depressive-symptom OR of 1.69. The authors flagged that most trials were low quality and called for larger, better-designed studies — which haven't really materialized. Recent smaller trials at 80 mg/day report significant improvements in mood symptoms, irritability, and anxiety. Mechanism is plausible (PLP is a cofactor for neurotransmitter synthesis) but causality isn't firmly pinned down.
Bottom line: Reasonable to try at ≤50 mg/day for mood-dominant PMS; stop within 3 cycles if no benefit. Don't sit at 100 mg/day indefinitely.
Evidence is mixed
Wyatt meta-analysis is positive but underlying trials are mostly low quality; no large, well-powered RCT has confirmed since. Doses approaching 100 mg/day cross into long-term neuropathy-risk territory.
How it works
How to take it
What to track
Bottom line: Stay at ≤50 mg/day unless treating active NVP or under clinician supervision. Discontinue immediately if you notice numbness, tingling, or balance problems.
3 commercial forms
Compare the main delivery options and what they’re best suited for.
Pyridoxine HCl
Most studiedThe classic supplemental form — pyridoxine bound to hydrochloride for stability. Requires liver conversion to PLP (the active coenzyme), but this conversion is reliable in healthy adults. Used in essentially every major clinical trial (Wyatt PMS, ACOG NVP guidance, deficiency correction studies). Cheapest form per mg.
Liver-converted to active PLP; reliable in healthy adults.
Pyridoxal-5-phosphate (P5P, PLP)
Active formThe biologically active coenzyme form. Skips liver conversion but is largely dephosphorylated in the intestine to pyridoxal before absorption, then re-phosphorylated. Plasma PLP rises higher per mg dose, but no convincing RCT shows superior clinical outcomes vs pyridoxine HCl in healthy adults. May be preferred in severe liver disease.
Higher peak plasma PLP; clinical outcome advantage not established.
Pyridoxamine
Limited supplement availabilityAnother natural form of vitamin B6 (alongside pyridoxine and pyridoxal). FDA classified it as a drug in 2009, restricting its sale as a dietary supplement in the US.
Restricted as a supplement in the US.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Sensory peripheral neuropathy — numbness, tingling, burning, ataxia. Classically described at 1–6 g/day for 12–40 months, but cases reported at 200 mg/day and lower with prolonged use. EFSA (2023) set a 12 mg/day adult UL. Usually reverses on discontinuation, but recovery can take months and is not always complete.
Photosensitivity dermatitis at very high chronic doses.
Who should avoid it
- People taking levodopa WITHOUT carbidopa for Parkinson's — pyridoxine accelerates peripheral L-dopa decarboxylation, blunting effect. Modern combination products (carbidopa-levodopa) are not affected.
- Anyone planning to take >100 mg/day long-term without medical supervision — neuropathy risk is real.
- People with active unexplained neurological symptoms (numbness/tingling) — get worked up first.
Pregnancy & breastfeeding
Pyridoxine 10–25 mg three to four times daily is ACOG-recommended first-line therapy for nausea/vomiting of pregnancy. Safety data covering hundreds of thousands of pregnancies (largely via the Diclegis/Diclectin combination) shows no increase in birth defect risk. The pregnancy RDA is 1.9 mg/day. Doses up to 100 mg/day are considered safe in pregnancy short-term; megadoses are not recommended.
Bottom line: Safe at RDA-equivalent and modest therapeutic doses (10–50 mg/day). Don't take >100 mg/day long-term without a clinician, and stop immediately at the first hint of numbness or tingling.
Interactions
Pyridoxine is a PLP cofactor for aromatic L-amino acid decarboxylase; accelerates peripheral conversion of L-dopa to dopamine before it reaches the brain, blunting effect. Modern carbidopa-levodopa combos block this peripheral conversion.
INH binds and inactivates PLP, causing peripheral neuropathy and seizures. Pyridoxine 10–50 mg/day is routinely co-prescribed with INH to prevent this.
Cycloserine increases urinary B6 loss and antagonizes PLP-dependent enzymes; supplementation recommended to prevent neurotoxicity and seizures.
Hydralazine can complex with PLP, increasing B6 requirements.
Forms inactive complex with PLP; supplementation often recommended.
Increase B6 catabolism; can lower plasma PLP and raise homocysteine over time. Very high B6 doses may reduce phenytoin levels.
High-dose pyridoxine may increase amiodarone-induced photosensitivity.
Protocols featuring Vitamin B6 (pyridoxine)
Evidence-backed routines where Vitamin B6 (pyridoxine) plays a role.
Trimester 1 Prenatal
maternal
The first trimester is the highest-stakes window of pregnancy nutritionally. Neural tube formation completes by week 4-6 (often before pregnancy is even known), organogenesis is in full swing, and the most common early-pregnancy symptom — morning sickness — affects 70-85% of pregnancies. This protocol covers the four nutritional priorities for trimester 1: a methylfolate-containing prenatal (the single most-evidenced intervention in obstetric nutrition for preventing neural tube defects), vitamin B6 + ginger for nausea (both ACOG-supported as first-line), choline for fetal brain and liver development (commonly under-consumed), and iron when ferritin is confirmed low. This protocol replaces your Fertility Prep — Women stack once pregnancy is confirmed. Many supplements that were fine pre-conception (ashwagandha, vitex, berberine, high-dose vitamin A, certain herbal blends) are contraindicated in pregnancy. Coordinate every supplement with your OB.
PMS Support
hormones
Premenstrual syndrome affects up to 75% of menstruating women in some form. The supplement literature is unusually solid here — magnesium, B6, calcium, and chasteberry each have multiple randomized trials supporting their use for the physical and emotional symptoms of PMS. Effect sizes are real but modest, and the stack works best when taken consistently across the cycle rather than only in the luteal phase. Severe PMS or PMDD warrants a conversation with your doctor — supplements are first-line for mild-to-moderate symptoms, not a substitute for proper care in severe cases.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Chickpeas, canned | 1 cup (1.1 mg) | 65% |
| Beef liver, pan-fried | 3 oz (0.9 mg) | 53% |
| Tuna, yellowfin, cooked | 3 oz (0.9 mg) | 53% |
| Salmon, sockeye, cooked | 3 oz (0.6 mg) | 35% |
| Chicken breast, roasted | 3 oz (0.5 mg) | 29% |
| Potato, baked with skin | 1 medium (0.4 mg) | 24% |
| Banana | 1 medium (0.4 mg) | 24% |
| Cottage cheese, low-fat | 1 cup (0.2 mg) | 12% |
| Squash, winter, baked | ½ cup (0.2 mg) | 12% |
| Rice, brown, cooked | 1 cup (0.1 mg) | 6% |
Chickpeas, canned
- Amount
- 1 cup (1.1 mg)
- %DV
- 65%
Beef liver, pan-fried
- Amount
- 3 oz (0.9 mg)
- %DV
- 53%
Tuna, yellowfin, cooked
- Amount
- 3 oz (0.9 mg)
- %DV
- 53%
Salmon, sockeye, cooked
- Amount
- 3 oz (0.6 mg)
- %DV
- 35%
Chicken breast, roasted
- Amount
- 3 oz (0.5 mg)
- %DV
- 29%
Potato, baked with skin
- Amount
- 1 medium (0.4 mg)
- %DV
- 24%
Banana
- Amount
- 1 medium (0.4 mg)
- %DV
- 24%
Cottage cheese, low-fat
- Amount
- 1 cup (0.2 mg)
- %DV
- 12%
Squash, winter, baked
- Amount
- ½ cup (0.2 mg)
- %DV
- 12%
Rice, brown, cooked
- Amount
- 1 cup (0.1 mg)
- %DV
- 6%
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
How does pyridoxine differ from P5P?⌄
Pyridoxine must be converted by the liver to the active form P5P. Both work for most people; P5P bypasses one conversion step and may be preferable in liver dysfunction.
Can pyridoxine cause nerve damage?⌄
Yes, at chronic doses above 100 to 200 mg per day. The upper limit is 100 mg per day. Stop the supplement and consult a doctor if you develop tingling or numbness.
Is pyridoxine safe in pregnancy?⌄
Yes, at low doses (10 to 25 mg) used for nausea relief. Higher doses should be discussed with your obstetrician.
Should I take pyridoxine with food?⌄
Either way works. Some people take it with breakfast to make it a habit; food does not significantly affect absorption.
References by claim
Correcting B6 deficiency
NIH Office of Dietary Supplements — Vitamin B6 — Health Professional Fact Sheet (2024) link
Safety
EFSA Panel on Nutrition, 2023 — EFSA Scientific Opinion on the Tolerable Upper Intake Level for Vitamin B6 (2023) link
Nausea and vomiting of pregnancy (NVP)
Premenstrual syndrome (PMS)
Wyatt et al., 1999 — BMJ — Efficacy of vitamin B-6 in premenstrual syndrome (1999) link
Track Vitamin B6 (pyridoxine) with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.
